Chronic Kidney Disease
📧 Sign up to get email alerts when something new happens for Chronic Kidney Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-07-20Clinical Trial Update: Effect of Empagliflozin on Podocyte Specific Proteins in African American Veterans With NDKD [Phase 4]
Phase 4 clinical trial evaluating the effect of empagliflozin on podocyte-specific proteins in African American veterans with non-diabetic k…
-
CLINICAL_TRIALS trial_result · 2025-07-20Clinical Trial Update: Cerebrovascular Dysregulation in Chronic Kidney Disease [NA]
This clinical trial update reports completion of the study and posting of results for cerebrovascular dysregulation in chronic kidney diseas…
-
CLINICAL_TRIALS research · 2025-07-18Clinical Trial Update: First-in-human Study to Examine Safety of a New Peritoneal Dialysis Device (WEAKID) in End-stage Kidney Disease Patients [NA]
A first-in-human safety study of a new peritoneal dialysis device (WEAKID) in patients with end-stage kidney disease is currently recruiting…
-
CLINICAL_TRIALS research · 2025-07-18Clinical Trial Update: Expanding and Promoting Alternative Care and kNowledge in Decision-making Trial [NA]
A clinical trial update shows enrollment is ongoing by invitation for a study titled Expanding and Promoting Alternative Care and Knowledge …
-
CLINICAL_TRIALS research · 2025-07-18Clinical Trial Update: Oral Absorbent and Probiotics in CKD Patients With PAD on Gut Microbiota, IncRNA, Metabolome, and Vascular Function [NA]
This Clinical Trial Update describes a study evaluating an oral absorbent and probiotics in chronic kidney disease patients with peripheral …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-07-18Clinical Trial Update: Study of Oral Uremic Toxin Absorbent and Probiotics to Retard the Progression of Chronic Kidney Disease [NA]
A clinical trial from National Taiwan University Hospital is evaluating an oral uremic toxin absorbent and probiotics to slow progression of…
-
CLINICAL_TRIALS trial_result · 2025-07-17Clinical Trial Update: Teach Back Method on Depression Levels in Hemodialysis Patients [NA]
Completed clinical trial evaluating the Teach Back Method on depression levels in adults undergoing hemodialysis.
-
CLINICAL_TRIALS research · 2025-07-17Clinical Trial Update: GENomic Predictors in A Multi-Ethnic Population With Kidney Disease Study
An ongoing multi-ethnic clinical study is investigating genomic predictors in individuals with chronic kidney disease, currently enrolling b…
-
CLINICAL_TRIALS research · 2025-07-17Clinical Trial Update: lncRNAs as a Biomarker to Assess the Therapeutic Impact of Oral Absorbent ± Probiotics in CKD Patients With PAD [NA]
Clinical trial update from National Taiwan University Hospital on using an oral carbon adsorbent with or without probiotics to assess the th…
-
CLINICAL_TRIALS research · 2025-07-17Clinical Trial Update: High Neutrophil-to-Lymphocyte Ratio and Patients With Hemodialysis
Clinical trial update indicating a study on high neutrophil-to-lymphocyte ratio in patients undergoing hemodialysis; the study is not yet re…
-
CLINICAL_TRIALS trial_result · 2025-07-16Clinical Trial Update: Exploring the Effectiveness and Safety of Amino Acid Peritoneal Dialysis Solution [Phase 4]
Phase 4 trial evaluating the effectiveness and safety of an amino acid peritoneal dialysis solution in kidney disease; results have been pos…
-
CLINICAL_TRIALS research · 2025-07-15Clinical Trial Update: APOL1 Genetic Testing Program for Living Donors, Part 2 [NA]
Northwestern University's APOL1 genetic testing program for living kidney donors (Part 2) has completed its trial update, evaluating APOL1 r…
-
CLINICAL_TRIALS trial_result · 2025-07-15Clinical Trial Update: RAYALDEE Non Interventional Study (NIS) on Effectiveness in ND-CKD SHPT Patients
A non-interventional study evaluating the effectiveness of RAYALDEE (paricalcitol) in non-dialysis CKD patients with secondary hyperparathyr…
-
CLINICAL_TRIALS trial_result · 2025-07-15Clinical Trial Update: Evaluating the Effect of the Valsalva Maneuver on Invasive Pain During Arteriovenous Fistula Cannulation in Hemodialysis Patients [NA]
A clinical trial is evaluating whether the Valsalva maneuver can reduce invasive pain during arteriovenous fistula cannulation in hemodialys…
-
CLINICAL_TRIALS trial_result · 2025-07-14Clinical Trial Update: Effect of Massage Therapy on Severity of Restless Legs Syndrome and Quality of Life in Hemodialysis Patients [NA]
This study completion reports on the effects of massage therapy on the severity of restless legs syndrome and quality of life in patients un…
-
FDA approval · 2025-07-11FDA Approved: KERENDIA — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)
The FDA approved a supplemental application for Kerendia (finerenone) submitted by Bayer HealthCare Pharmaceuticals Inc. The action concerns…
-
EMA approval · 2025-07-11EMA Authorised: Epoetin Alfa Hexal (epoetin alfa) — Hexal AG
The EMA authorised Epoetin Alfa Hexal (epoetin alfa) from Hexal AG to treat anemia associated with chronic kidney disease and related condit…
-
EMA approval · 2025-07-11EMA Authorised: Binocrit (epoetin alfa) — Sandoz GmbH
EMA authorised Binocrit (epoetin alfa) by Sandoz GmbH for the treatment of anemia associated with chronic kidney disease, myelodysplastic sy…
-
EMA approval · 2025-07-11EMA Authorised: Abseamed (epoetin alfa) — Medice Arzneimittel Pütter GmbH Co. KG
EMA has authorised Abseamed, an epoetin alfa product by Medice, for treatment of anemia associated with chronic kidney disease and certain h…
-
CLINICAL_TRIALS research · 2025-07-11Clinical Trial Update: Prevalence and Risk Factors of Hyperkalemia in Non-Dialysis Chronic Kidney Disease Patients in Community
This clinical trial investigates the prevalence and risk factors of hyperkalemia among non-dialysis chronic kidney disease patients in commu…
-
CLINICAL_TRIALS research · 2025-07-11Clinical Trial Update: Vascular Effects of SGLT2i in Non-diabetic CKD [Phase 2]
Phase 2 trial update on vascular effects of SGLT2 inhibitors in non-diabetic chronic kidney disease; recruitment has not yet started.
-
CLINICAL_TRIALS research · 2025-07-11Clinical Trial Update: Epigenetics and NCD Prevention in Kazakhstan: Personalized Approaches and Biological Age Prediction
A recruiting clinical trial in Kazakhstan investigates epigenetic-based prevention for non-communicable diseases, with personalized approach…
-
CLINICAL_TRIALS research · 2025-07-10Clinical Trial Update: The Effect of the Nutraceutical (-)- Epicatechin on Myosteatosis in Patients With Advanced CKD [NA]
A clinical trial is evaluating whether the nutraceutical epicatechin can improve myosteatosis in patients with advanced chronic kidney disea…
-
CLINICAL_TRIALS research · 2025-07-10Clinical Trial Update: Inorganic Pyrophosphate Homeostasis (PPi) in Pediatric Chronic Kidney Disease [NA]
An update on an ongoing pediatric CKD trial evaluating inorganic pyrophosphate homeostasis; the study is currently recruiting and no results…
-
CLINICAL_TRIALS trial_result · 2025-07-09Clinical Trial Update: A Study to Learn How Safe the Study Drug Finerenone is and How Well it Works in Indian People With Long-term Decrease in the Kidneys' Ability to Work Properly (Chronic Kidney Disease) Together With Type 2 Diabetes Mellitus [Phase 4]
A Phase 4 trial evaluating the safety and effectiveness of finerenone in Indian individuals with chronic kidney disease and type 2 diabetes …